eylea

1 article

All articles tagged "eylea"

Laboratory technician growing monoclonal antibodies in roller bottles — the core technology behind Regeneron's antibody-based drug platform

Regeneron Pharmaceuticals: EYLEA Franchise, Dupixent Immunology, and Drug Pipeline

Regeneron Pharmaceuticals is a biotech leader built on proprietary antibody technology (VelociSuite). This explainer covers the EYLEA/EYLEA HD ophthalmology franchise, Dupixent immunology partnership with Sanofi, Libtayo oncology, pipeline diversification into obesity and gene therapy, and key risks.

May 26, 2026